OUR FOCUS

Developing next generation peptide therapeutics for liver disease and immuno-oncology

OUR PROGRAMS

liver icon
Peptide-Based Therapeutics for Liver Diseases

READ MORE >

Peptide-Conjugated Immunostimulants for Cancer - Icon
Peptide-Conjugated Immunostimulants for Cancer

READ MORE >

Intranasal vaccines for Anthrax and Influenza - icon
Intranasal vaccines for Anthrax and Influenza

READ MORE >

OUR PIPELINE

Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcellTM), and conjugated immunostimulants for the treatment of cancer (ALT-702). In addition, we are developing intranasal vaccine programs for anthrax and influenza.

LIVER THERAPIES

liver therapies iconALT-801
liver therapies iconHepTcell™

CANCER

cancer iconALT-702

INTRANASAL VACCINES

intranasal vaccines iconNasoVAX™
intranasal vaccines iconNasoShield™
VIEW PIPELINE